Cargando…
Analysis and Validation of Human Targets and Treatments Using a Hepatocellular Carcinoma–Immune Humanized Mouse Model
BACKGROUND AND AIMS: Recent development of multiple treatments for human hepatocellular carcinoma (HCC) has allowed for the selection of combination therapy to enhance the effectiveness of monotherapy. Optimal selection of therapies is based on both HCC and its microenvironment. Therefore, it is cri...
Autores principales: | Zhao, Yue, Wang, Jiaxu, Liu, Wai Nam, Fong, Shin Yie, Shuen, Timothy Wai Ho, Liu, Min, Harden, Sarah, Tan, Sue Yee, Cheng, Jia Ying, Tan, Wilson Wei Sheng, Chan, Jerry Kok Yen, Chee, Cheng Ean, Lee, Guan Huei, Toh, Han Chong, Lim, Seng Gee, Wan, Yue, Chen, Qingfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540409/ https://www.ncbi.nlm.nih.gov/pubmed/33738839 http://dx.doi.org/10.1002/hep.31812 |
Ejemplares similares
-
Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy
por: Zhao, Yue, et al.
Publicado: (2018) -
Establishment and Characterization of Humanized Mouse NPC-PDX Model for Testing Immunotherapy
por: Liu, Wai Nam, et al.
Publicado: (2020) -
Cancer Immunotherapies and Humanized Mouse Drug Testing Platforms()
por: Chen, Qingfeng, et al.
Publicado: (2019) -
Decreased Innate Migration of Pro-Inflammatory M1 Macrophages through the Mesothelial Membrane Is Affected by Ceramide Kinase and Ceramide 1-P
por: Ku, Chee Wai, et al.
Publicado: (2022) -
Successful targeting of PD-1/PD-L1 with chimeric antigen receptor-natural killer cells and nivolumab in a humanized mouse cancer model
por: Liu, Wai Nam, et al.
Publicado: (2022)